YYZ Pharmatech has created enabling technologies that overcome three fundamental challenges in modern medicine: 1) Harness blood as the most data rich sample type 2) Identify low-abundance markers of disease 3) Develop ultra-sensitive assays against the most biologically significant biomolecules About YYZ Pharmatech: YYZ builds innovative technology platforms to enable new insights in modern medicine, with breakthroughs in the ultra-sensitive discovery & measurement of biomolecules. Supported by over 20 years of published research and backed by two visionary family offices, YYZ’s technology suite is powered by: DPiPSA™ for Discovery: (Database-Driven Proteome Intact Partition Statistical Analysis) Unbiased & statistically rigorous bioinformatics for next-generation discovery & stratification. ELiMSA™ for Measurement: (Enzyme Linked Mass Spectrometric Assay) Ultra-sensitive & quantitative assay technology with extensive life science applications. YYZ is the commercialization partner of the Marshall Team at Toronto Metropolitan University (formerly Ryerson University).
